News Image

Nurix Therapeutics to Participate in Upcoming Investor Conferences

Provided By GlobeNewswire

Last update: Mar 4, 2025

SAN FRANCISCO, March 04, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that Arthur T. Sands, M.D., Ph.D., president and chief executive officer of Nurix, and Hans van Houte, chief financial officer of Nurix, will participate in the following conferences in March.

Read more at globenewswire.com

NURIX THERAPEUTICS INC

NASDAQ:NRIX (7/2/2025, 3:26:54 PM)

12.55

+0.84 (+7.17%)



Find more stocks in the Stock Screener

Follow ChartMill for more